BERGAMINI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 11.170
EU - Europa 10.473
AS - Asia 4.725
SA - Sud America 646
AF - Africa 71
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 11
Totale 27.116
Nazione #
US - Stati Uniti d'America 10.825
IT - Italia 4.643
GB - Regno Unito 1.886
CN - Cina 1.483
SG - Singapore 1.424
RU - Federazione Russa 1.295
SE - Svezia 860
HK - Hong Kong 744
DE - Germania 673
BR - Brasile 519
VN - Vietnam 277
CA - Canada 257
TR - Turchia 207
NL - Olanda 198
UA - Ucraina 193
FR - Francia 162
FI - Finlandia 143
KR - Corea 143
BG - Bulgaria 107
IN - India 96
ID - Indonesia 74
JP - Giappone 66
AR - Argentina 57
MX - Messico 48
PL - Polonia 39
IR - Iran 38
BE - Belgio 37
BD - Bangladesh 36
CH - Svizzera 33
ZA - Sudafrica 33
IE - Irlanda 29
MY - Malesia 29
ES - Italia 28
EC - Ecuador 26
AT - Austria 22
AU - Australia 20
CR - Costa Rica 18
DK - Danimarca 17
TW - Taiwan 16
IQ - Iraq 15
LT - Lituania 15
AE - Emirati Arabi Uniti 14
CZ - Repubblica Ceca 12
MA - Marocco 12
RO - Romania 12
HU - Ungheria 11
CL - Cile 10
EU - Europa 10
PK - Pakistan 10
PT - Portogallo 10
DO - Repubblica Dominicana 9
LU - Lussemburgo 9
CO - Colombia 8
PY - Paraguay 8
AL - Albania 7
NO - Norvegia 7
VE - Venezuela 7
AZ - Azerbaigian 6
PE - Perù 6
PH - Filippine 6
UZ - Uzbekistan 6
HN - Honduras 5
MT - Malta 5
TN - Tunisia 5
BY - Bielorussia 4
EG - Egitto 4
GR - Grecia 4
IL - Israele 4
KE - Kenya 4
SA - Arabia Saudita 4
UY - Uruguay 4
GE - Georgia 3
MD - Moldavia 3
NP - Nepal 3
PA - Panama 3
TH - Thailandia 3
AM - Armenia 2
HR - Croazia 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
MC - Monaco 2
MZ - Mozambico 2
OM - Oman 2
PS - Palestinian Territory 2
SN - Senegal 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CV - Capo Verde 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
Totale 27.105
Città #
Southend 1.401
Santa Clara 1.325
Moscow 1.069
Singapore 978
Ashburn 968
Fairfield 861
Chandler 795
Hong Kong 710
Woodbridge 542
Dearborn 452
Houston 445
Milan 406
Ann Arbor 400
Hefei 390
Jacksonville 389
Nyköping 389
Rome 335
Wilmington 327
Seattle 319
Beijing 289
Cambridge 270
London 270
Modena 218
Chicago 217
Ottawa 194
Los Angeles 193
New York 148
Naples 127
Seoul 127
The Dalles 117
Princeton 113
Sofia 107
Izmir 101
Eugene 95
San Diego 93
Dallas 92
Salt Lake City 80
Council Bluffs 75
Ho Chi Minh City 73
Hanoi 71
Bari 69
Shanghai 69
Bologna 66
Turin 66
Helsinki 62
Florence 61
Jakarta 59
Buffalo 57
Bremen 54
Redwood City 53
São Paulo 50
Munich 48
Genoa 46
Tokyo 45
Tampa 43
Elk Grove Village 41
San Jose 39
Falls Church 38
Des Moines 37
Reggio Emilia 37
Guangzhou 35
Palermo 35
Parma 34
Catania 33
Columbus 33
Verona 32
Brussels 31
Warsaw 30
Boardman 29
Dublin 29
Fremont 29
Lancaster 28
Brescia 26
Kowloon 26
Toronto 26
Livorno 25
Norwalk 25
Phoenix 25
Nanjing 23
Lucca 22
Padova 22
Reggio Nell'emilia 21
Boston 19
Dong Ket 19
New Delhi 19
Poplar 19
Rio de Janeiro 19
Salerno 19
Sterling 19
Leawood 18
Messina 18
Nuremberg 18
Orem 18
Cagliari 17
San José 17
San Mateo 17
Zhengzhou 17
Brooklyn 15
Denver 15
Kunming 15
Totale 17.548
Nome #
Effetto della N-acetilcisteina sulla progressione dell'insufficienza renale cronica nel ratto 4.123
Research of Prostate Cancer Urinary Diagnostic Biomarkers by Proteomics: The Noteworthy Influence of Inflammation 1.123
Allopregnanolone serum levels in female migraineurs 734
Relationship of asymmetric dimethylarginine to haemodialysis hypotension 417
Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis 371
Long-term n-acetylcysteine and l-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes 342
Enriched sera protein profiling for detection of non-small cell lung cancer biomarkers. 336
Non-bacterial protein expression in periodontal pockets by proteome analysis 324
Proteomic profiling during atherosclerosis progression: Effect of nebivolol treatment 314
Analysis of protein expression in periodontal pocket tissue: a preliminary study 313
Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study 310
Serum protein changes in a rat model of chronic pain show a correlation between animal and humans 308
Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages 299
Impairment of 8-iso-PGF(2ALPHA) isoprostane metabolism by dietary conjugated linoleic acid (CLA) 293
Studio degli effetti della LDL aferesi in pazienti affetti da ipercolesterolemia familiare 291
Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache 284
Proteomic research of proteins involved in pain expression in an animal model of chronic pain 282
Prooxidant activity of ferrioxamine in isolated rat hepatocytes and linoleic acid micelles 282
Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache 266
New horizon in dialysis depuration: Characterization of a polysulfone membrane able to break the 'albumin wall' 259
“VITAMIN E MODULATES BENZOYL PEROXIDE TOXICITY IN HUMAN KERATINOCYTES” 258
Oxidative stress in fibroblasts from patients with pseudoxanthoma elasticum: possible role in the pathogenesis of clinical manifestations 255
Proteomic profiling during atherosclerosis progression using SELDI-TOF-MS: Effect of darbepoetin treatment 253
Can prostatitis to be a confounding parameter in prostatic proteomic profile designation? 253
Analisi tissutale proteomica della tasca parodontale. Uno studio pilota Periodontal pocket tissue analysis using proteome. A pilot study 253
Antioxidant activity of carotenoids: an electron spin resonance study of beta-carotene and lutein interaction with free radicals generated in a chemical system 252
N-Acetylcysteine negatively modulates nitric oxide production in endotoxin-treated rats through inhibition of NF-ĸB activation 250
Proteomic analisys of protein extraction during hemofiltration with on-line endogenous reinfusion (HFR) using different polysulphone membranes 246
Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments 245
High-abundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins. 243
Inflammation: an important parameter in the search of prostate cancer biomarkers 236
An unusual case of signet ring cell adenocarcinoma of the prostate 232
N-Acetylcysteine inhibits in vivo nitric oxide production by inducible nitric oxide synthase 232
Discovery of restless legs syndrome plasmatic biomarkers by proteomic analysis 231
Role of oxidative stress in progressive kidney failure 231
Comparative proteomic analysis between the gingival crevicular fluid and the corresponding periodontal pocket: a preliminary study 228
Analisi proteo mica nella neoplasia prostatica: Risultati preliminari e nuove prospettive. 225
Effect of alpha-tocopherol and N-acetylcysteine on benzoyl peroxide toxicity in human keratinocytes 225
Optimizing protein recovery yield from serum samples treated with beads technology. 224
Quantificazione del p-cresol solfato nel plasma di pazienti uremici mediante MNR. 222
Influence of different hemodialysis membranes on red blood cell susceptibility to oxidative stress 218
Quantification of p-cresol sulphate in human plasma by selected reaction monitoring. 216
Metabolism of 8-iso-PGF2 alpha isoprostane is impaired by conjugated linoleic acid (CLA) 216
“Role of NO in hypotension prone dialytic patients” 215
Oxidative stress in renal patients 211
Proteomic serum profile in menstrual-related and post menopause migraine 211
Detection of predictive urinary biomarkers of nephropathy in type 1 and type 2 diabetes by proteomic analysis 210
Urine proteomic analysis in patients with cronic headache and overuse of analgesic drugs: possible relation with renal damage 207
Proteomic profile of non-bacterial proteins in periodontal pockets: a pilot study. 207
New insights on the pathogenesis of clinical manifestations in Pseudoxathoma elasticum. 207
A Proteomic Analysis of Discolored Tooth Surfaces after the Use of 0.12% Chlorhexidine (CHX) Mouthwash and CHX Provided with an Anti-Discoloration System (ADS) 204
Dehydroepiandrosterone Sulfate, Dehydroepiandrosterone, 5α-Dihydroprogesterone and Pregnenolone: Serum Analysis and Correlation Between Migraine and Non-headache Control Females 204
Proteomic Analysis of PTCH1+/- Fibroblast Lysate and Conditioned Culture Media Isolated from the Skin of Healthy Subjects and Nevoid Basal Cell Carcinoma Syndrome Patients. 203
Proteomic profile of retained proteins from hemodiafiltration with on-line endogenous reinfusion (SUPRA) cartridge. 199
Superhighflux therapies for hemodialysis: ultrafiltrate proteomic profile and protein identification by on-chip elution. 199
Antioxidants modulates benzoyl-peroxide toxicity in human keratinocytes 198
Nitric oxide and hypotension in haemodialysis patients. 196
Effetti della N-acetilcisteina in condizioni di stress ossidativo 196
“The highly reducing sugar 2-deoxy-d-ribose induces apoptosis in human fibroblasts by reduced glutathione depletion and cytoskeletal disruption” 191
The comparison of the proteomic profile of periodontal pocket and of corresponding gingival crevicular fluid to study periodontal disease biomarkers: feasibility study. biomarkers: feasibility study 186
Detection of serum protein profile changes in atherosclerosis 185
Evaluation of a possible relationship between medication-overuse headache and potential renal dysfunctions by a proteomic study on urine samples 184
Evaluation of potential cardiovascular risk protein biomarkers in high severity restless legs syndrome 184
Evalutation of proteomic profile in menstrually-related migraine 183
Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study 182
Biomarkers discovery of renal alterations in urine of diabetic patients by proteomic analysis 181
Quantification of P-cresol sulphate in human plasma of uremic patients by MRM 181
POTENTIAL ROLE OF PROTEOMIC ANALYSIS IN PROSTATE CANCER DIAGNOSIS 180
Chronic inflammation in end stage renal disease: markers of oxidative stress and redox modification 180
Effect of nebivolol treatment on proteomic profiling during atherosclerosis progression. 178
Oxidative stress and experimental shock 177
Redox regulation, cytokines, and nitric oxide in inflammation 171
Proteomic serum profile of female migraineurs 171
Evaluation of proteomic profile in menstrual-related migraine 170
Heparin-induced lipoprotein precipitation apheresis in dyslipidemic patients: A multiparametric assessment 170
Bioactive Glasses in Periodontal Regeneration: Existing Strategies and Future Prospects—A Literature Review 166
Studio STEPS: Superior Therapies for hemodialysis. Approccio proteomico. 165
The influence of inflammation in the search of discriminatory biomarkers for prostate cancer: a proteomic study 162
Steps Study: Superhighflux therapies for hemodialysis. A proteomic approach. 160
Proteomic profile of retained proteins from hfr cartridge 158
Cytokine and nitric oxide redox regulation in vivo 157
Metabolism of 8-iso-PGF2 alpha and conjugated linoleic acid (CLA) in vivo and in X-adrenoleukodystrophy fibroblast. 147
Plasma antioxidants modifications during haemodialysis 147
Dehydroepiandrosterone sulfate, dehydroepiandrosterone, 5α-dihydroprogesterone and pregnenolone in women with migraine: analysis of serum levels and correlation with age, migraine years and frequency 147
Proteomic analysis of proteins adsorbed by resin cartridge filter during hemodiafitration with online endogenous reinfusion. 144
Proteomic analysis of PTCH1+/- fibroblast lysate and conditioned culture media isolated from the skin of healthy subjects and Nevoid Basal Cell Carcinoma Syndrome (NBCCS) patients. 143
PROTEOMICS AS DIAGNOSTIC MARKERS 142
Diagnostic proteomic markers to detect kidney diseases 136
Free radical induced oxidative protein modification in kidney diseases: proteomic detection 135
Influence of tooth-brushing on early healing after access flap surgery: A randomized controlled preliminary study 131
Urinary proteomics in biomarker discovery of kidney-related disorders: Diabetic nephropathy and drug-induced nephrotoxicity in chronic headache 128
Urinary proteomics reveals promising biomarkers in menstrually related and post-menopause migraine 128
Validation of prostate cancer biomarkers and inflammation: a proteomic study 124
Erratum to: Proteomic analysis of protein extraction during hemofiltration with on-line endogenous reinfusion (HFR) using different polysulphone membranes [JMater Sci:MaterMed, 25, (2014) 2691-2698, DOI 10.1007/s10856-014-5290-5] 122
Urinary proteomic profiles of prostate cancer with different risk of progression and correlation with histopathological features 120
Proteomics to identify free radical induced oxidative protein modifications as biomarkers associated to type 2 diabetic nephropathy 119
Proteomic analysis to discover early urinary biomarkers of type 2 diabetic nephropathy 118
No evidences of oxidative injury associated with slow intravenous administration of ferric gluconate during haemodialysis 116
Markers of oxidative stress and antioxidant status in haemodialysis patients 115
Role of nitric oxide generating pathway in haemodialysis hypotension 113
Totale 26.279
Categoria #
all - tutte 94.892
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.892


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.317 0 0 0 0 0 121 151 287 82 327 239 110
2021/20222.118 66 184 167 440 45 77 91 106 217 156 330 239
2022/20232.978 221 307 222 272 291 415 111 298 342 113 208 178
2023/20244.125 105 173 218 271 426 547 824 612 140 342 190 277
2024/20256.232 330 251 237 477 1.102 846 488 353 543 260 575 770
2025/20264.309 490 282 575 984 1.458 520 0 0 0 0 0 0
Totale 27.313